STIA 3331
Disruptive Technologies
Without Proactive strategies to manage intellectual property (IP) and regulatory aspects of commercializing new technologies and discoveries, new ventures often fail or do not capture appropriate economic value. Based on the premise that innovative approaches to regulatory and IP issues can be as critical to success as the quality of the new technologies, this seminar will provide a grounding of the key IP and regulatory challenges facing new technology and healthcare ventures and examine case studies of successful proactive approaches.
Sources
- Course catalogue ↗2026-2027